Martin has over 20 years of experience in product and business development, bringing to market several NCEs, protein scaffolds, cell and gene therapy vaccines, and platforms. His previous roles include co-founder of Sinfonie Life Science Management GmbH, CEO of Pieris and Revotar, Vice President BD at MediGene, and European Commercial Director at Tripos (now Certara). In 2004, he was a finalist for Deutscher Zukunftspreis, the Federal President’s award for technology and innovation.
Key areas of expertise
- Biotech, Pharma
- Cell and Gene Therapy, ATMPs
- Biologicals, Chemicals, CDMOs
- Digital Health & Data Science
- Intellectual Property
- Strategy and M&A